Acquisition agreement for Specifar PharmaAcquisition Agreement • January 28th, 2022
Contract Type FiledJanuary 28th, 2022Watson has acquired the privately-held multinational generic pharmaceutical developer, manufacturer and marketer for EUR 400 million ($562 million) in cash and certain contingent consideration.